Skip to main content
Top
Published in: Systematic Reviews 1/2024

Open Access 01-12-2024 | COVID-19 | Research

The quality of COVID-19 systematic reviews during the coronavirus 2019 pandemic: an exploratory comparison

Authors: Kevin T. McDermott, Mark Perry, Willemijn Linden, Rachel Croft, Robert Wolff, Jos Kleijnen

Published in: Systematic Reviews | Issue 1/2024

Login to get access

Abstract

Background

The unprecedented volume and speed at which COVID-19-related systematic reviews (SRs) may have been produced has raised questions regarding the quality of this evidence. It is feasible that pandemic-related factors may have led to an impairment in quality (reduced internal validity, increased risk of bias [RoB]). This may have serious implications for decision-making related to public health and individual healthcare.

Objective

The primary objective was to compare the quality of SRs published during the pandemic that were related to COVID-19 with SRs published during the pandemic that were unrelated to COVID-19 (all of which were fully appraised in the KSR Evidence database of SRs in healthcare). Our secondary objective was to compare the quality of SRs published during the pandemic (regardless of research topic), with SRs published pre-pandemic.

Methods

We compared all SRs related to COVID-19 to all SRs unrelated to COVID-19 that (i) were published during the pandemic (between 1st March 2020 and September 14, 2022), (ii) were included in KSR Evidence, and (iii) had been appraised using the ROBIS tool. We then compared all SRs published during the pandemic (regardless of research topic) with a pre-pandemic sample of SRs.

Results

For SRs published during the pandemic, we found there was no statistically significant difference in quality between those SRs tagged as being related to COVID-19 and those that were not [relative risk (RR) of low RoB for COVID-19 versus COVID-19-unrelated reviews: 0.94; 95% confidence interval (CI): 0.66 to 1.34]. Generally, COVID-19 SRs and COVID-19-unrelated SRs were both of low quality with only 10% of COVID-19 reviews and 11% of COVID-19-unrelated reviews rated as low RoB. However, SRs (regardless of topic) published during the pandemic were of lower quality than those published pre-pandemic (RR for low RoB for ‘during pandemic’ versus ‘pre-pandemic’: 0.30; 95% CI: 0.26 to 0.34) with 11% of pandemic and 36% of pre-pandemic SRs rated as low RoB.

Conclusion

These results suggest COVID-19 and COVID-19-unrelated SRs published during the pandemic are equally of low quality. SRs published during the pandemic were generally lower quality compared with SRs published pre-pandemic irrespective of COVID-19 focus. Moreover, SR quality in general is seriously lacking, and considerable efforts need to be made to substantially improve the quality and rigour of the SR process.
Literature
1.
go back to reference Mahase E. China coronavirus: WHO declares international emergency as death toll exceeds 200. BMJ. 2020;368:m408.CrossRefPubMed Mahase E. China coronavirus: WHO declares international emergency as death toll exceeds 200. BMJ. 2020;368:m408.CrossRefPubMed
5.
go back to reference Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126(5):376–80.CrossRefPubMed Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126(5):376–80.CrossRefPubMed
6.
go back to reference Pussegoda K, Turner L, Garritty C, Mayhew A, Skidmore B, Stevens A, et al. Systematic review adherence to methodological or reporting quality. Syst Rev. 2017;6(1):131.CrossRefPubMedPubMedCentral Pussegoda K, Turner L, Garritty C, Mayhew A, Skidmore B, Stevens A, et al. Systematic review adherence to methodological or reporting quality. Syst Rev. 2017;6(1):131.CrossRefPubMedPubMedCentral
7.
go back to reference Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–40.CrossRefPubMed Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–40.CrossRefPubMed
13.
go back to reference Quinn TJ, Burton JK, Carter B, Cooper N, Dwan K, Field R, et al. Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Med. 2021;19(1):46.CrossRefPubMedPubMedCentral Quinn TJ, Burton JK, Carter B, Cooper N, Dwan K, Field R, et al. Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Med. 2021;19(1):46.CrossRefPubMedPubMedCentral
14.
go back to reference Jung RG, Di Santo P, Clifford C, Prosperi-Porta G, Skanes S, Hung A, et al. Methodological quality of COVID-19 clinical research. Nat Commun. 2021;12(1):943.CrossRefPubMedPubMedCentral Jung RG, Di Santo P, Clifford C, Prosperi-Porta G, Skanes S, Hung A, et al. Methodological quality of COVID-19 clinical research. Nat Commun. 2021;12(1):943.CrossRefPubMedPubMedCentral
15.
go back to reference Dang A, Madiraju S, Venkateswara Rao P JM N.S. G, Digijarala S, et al. Critical appraisal of the risk of bias in systematic reviews and metaanalyses pertaining to COVID-19, coronaviruses. Coronaviruses. 2022;3(2):52–8.CrossRef Dang A, Madiraju S, Venkateswara Rao P JM N.S. G, Digijarala S, et al. Critical appraisal of the risk of bias in systematic reviews and metaanalyses pertaining to COVID-19, coronaviruses. Coronaviruses. 2022;3(2):52–8.CrossRef
16.
go back to reference Li Y, Cao L, Zhang Z, Hou L, Qin Y, Hui X, et al. Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping. J Clin Epidemiol. 2021;135:17–28.CrossRefPubMedPubMedCentral Li Y, Cao L, Zhang Z, Hou L, Qin Y, Hui X, et al. Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping. J Clin Epidemiol. 2021;135:17–28.CrossRefPubMedPubMedCentral
17.
go back to reference Baumeister A, Corrin T, Abid H, Young KM, Ayache D, Waddell L. The quality of systematic reviews and other synthesis in the time of COVID-19. Epidemiol Infect. 2021;149:e182.CrossRefPubMed Baumeister A, Corrin T, Abid H, Young KM, Ayache D, Waddell L. The quality of systematic reviews and other synthesis in the time of COVID-19. Epidemiol Infect. 2021;149:e182.CrossRefPubMed
18.
go back to reference Chen Y, Li L, Zhang Q, Liu H, Huang Y, Lin S, et al. Epidemiology, methodological quality, and reporting characteristics of systematic reviews and meta-analyses on coronavirus disease 2019: a cross-sectional study. Medicine (Baltimore). 2021;100(47):e27950.CrossRefPubMed Chen Y, Li L, Zhang Q, Liu H, Huang Y, Lin S, et al. Epidemiology, methodological quality, and reporting characteristics of systematic reviews and meta-analyses on coronavirus disease 2019: a cross-sectional study. Medicine (Baltimore). 2021;100(47):e27950.CrossRefPubMed
19.
go back to reference Abbott R, Bethel A, Rogers M, Whear R, Orr N, Shaw L, et al. Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study. BMJ Evid Based Med. 2022;27(3):169–77.CrossRefPubMed Abbott R, Bethel A, Rogers M, Whear R, Orr N, Shaw L, et al. Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study. BMJ Evid Based Med. 2022;27(3):169–77.CrossRefPubMed
20.
go back to reference Lunny C, Ramasubbu C, Puil L, Liu T, Gerrish S, Salzwedel DM, et al. Over half of clinical practice guidelines use non-systematic methods to inform recommendations: a methods study. PLoS ONE. 2021;16(4):e0250356.CrossRefPubMedPubMedCentral Lunny C, Ramasubbu C, Puil L, Liu T, Gerrish S, Salzwedel DM, et al. Over half of clinical practice guidelines use non-systematic methods to inform recommendations: a methods study. PLoS ONE. 2021;16(4):e0250356.CrossRefPubMedPubMedCentral
21.
go back to reference Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–34.CrossRefPubMedPubMedCentral Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–34.CrossRefPubMedPubMedCentral
22.
go back to reference Bühn S, Mathes T, Prengel P, Wegewitz U, Ostermann T, Robens S, et al. The risk of bias in systematic reviews tool showed fair reliability and good construct validity. J Clin Epidemiol. 2017;91:121–8.CrossRefPubMed Bühn S, Mathes T, Prengel P, Wegewitz U, Ostermann T, Robens S, et al. The risk of bias in systematic reviews tool showed fair reliability and good construct validity. J Clin Epidemiol. 2017;91:121–8.CrossRefPubMed
24.
go back to reference Alexander PE, Debono VB, Mammen MJ, Iorio A, Aryal K, Deng D, et al. COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine. J Clin Epidemiol. 2020;123:120–6.CrossRefPubMedPubMedCentral Alexander PE, Debono VB, Mammen MJ, Iorio A, Aryal K, Deng D, et al. COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine. J Clin Epidemiol. 2020;123:120–6.CrossRefPubMedPubMedCentral
25.
26.
go back to reference McDermott KT, Noake C, Wolff R, Bauld L, Espina C, Foucaud J, et al. Digital interventions to moderate physical inactivity and/or nutrition in young people: a Cancer Prevention Europe overview of systematic reviews. Front Digit Health. 2023;5:1185586.CrossRefPubMedPubMedCentral McDermott KT, Noake C, Wolff R, Bauld L, Espina C, Foucaud J, et al. Digital interventions to moderate physical inactivity and/or nutrition in young people: a Cancer Prevention Europe overview of systematic reviews. Front Digit Health. 2023;5:1185586.CrossRefPubMedPubMedCentral
27.
go back to reference McDermott KT, Noake C, Wolff R, Espina C, Foucaud J, Steindorf K, et al. Digital interventions to moderate alcohol consumption in young people: a Cancer Prevention Europe overview of systematic reviews. Front Digit Health. 2023;5:1178407.CrossRefPubMedPubMedCentral McDermott KT, Noake C, Wolff R, Espina C, Foucaud J, Steindorf K, et al. Digital interventions to moderate alcohol consumption in young people: a Cancer Prevention Europe overview of systematic reviews. Front Digit Health. 2023;5:1178407.CrossRefPubMedPubMedCentral
28.
go back to reference Lake J, Lawrence KA, Martinez Alonso E, Gonzales V, LaFleur J. Quality of systematic reviews in HIV: the case of clinical outcomes associated with patient medication adherence. J Evid Based Med. 2021;14(1):7–16.CrossRefPubMed Lake J, Lawrence KA, Martinez Alonso E, Gonzales V, LaFleur J. Quality of systematic reviews in HIV: the case of clinical outcomes associated with patient medication adherence. J Evid Based Med. 2021;14(1):7–16.CrossRefPubMed
Metadata
Title
The quality of COVID-19 systematic reviews during the coronavirus 2019 pandemic: an exploratory comparison
Authors
Kevin T. McDermott
Mark Perry
Willemijn Linden
Rachel Croft
Robert Wolff
Jos Kleijnen
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
COVID-19
Published in
Systematic Reviews / Issue 1/2024
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-024-02552-x

Other articles of this Issue 1/2024

Systematic Reviews 1/2024 Go to the issue